{"id":"https://openalex.org/W2767409693","doi":"https://doi.org/10.4049/jimmunol.196.supp.74.10","title":"BET bromodomain inhibition synergizes with immune checkpoint blockade to facilitate anti-tumor response in a murine model of non-small cell lung cancer harboring activating KRAS mutation","display_name":"BET bromodomain inhibition synergizes with immune checkpoint blockade to facilitate anti-tumor response in a murine model of non-small cell lung cancer harboring activating KRAS mutation","publication_year":2016,"publication_date":"2016-05-01","ids":{"openalex":"https://openalex.org/W2767409693","doi":"https://doi.org/10.4049/jimmunol.196.supp.74.10","mag":"2767409693"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.196.supp.74.10","doi":"https://doi.org/10.4049/jimmunol.196.supp.74.10","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.196.supp.74.10","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026258084","display_name":"Dennis O. Adeegbe","orcid":"https://orcid.org/0000-0001-9233-3328","observed_orcids":["https://orcid.org/0000-0001-9233-3328"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis O Adeegbe","raw_affiliation_strings":["Dana-Farber Cancer Inst","1Dana-Farber Cancer Inst"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Inst","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"1Dana-Farber Cancer Inst","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075310347","display_name":"Gordon James Freeman","orcid":"https://orcid.org/0000-0002-7210-5616","observed_orcids":["https://orcid.org/0000-0002-7210-5616"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gordon J Freeman","raw_affiliation_strings":["Dana-Farber Cancer Inst","1Dana-Farber Cancer Inst"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Inst","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"1Dana-Farber Cancer Inst","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019034689","display_name":"Kwok\u2010Kin Wong","orcid":"https://orcid.org/0000-0001-6323-235X","observed_orcids":["https://orcid.org/0000-0001-6323-235X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kwok-Kin Wong","raw_affiliation_strings":["Dana-Farber Cancer Inst","1Dana-Farber Cancer Inst"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Inst","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"1Dana-Farber Cancer Inst","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"196","issue":"1_Supplement","first_page":"74.10","last_page":"74.10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5425000190734863,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5425000190734863,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.44190001487731934,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bet-bromodomain-inhibition","display_name":"BET bromodomain inhibition","score":0.8840000033378601},{"id":"https://openalex.org/keywords/jq1","display_name":"JQ1","score":0.9929999709129333},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.9589999914169312},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.9520000219345093},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9599999785423279},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.9660000205039978},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7160000205039978},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.8029999732971191},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.949999988079071},{"id":"https://openalex.org/keywords/cd8-t-cell-activation","display_name":"CD8+ T cell activation","score":0.8199999928474426},{"id":"https://openalex.org/keywords/ifn-gamma-secretion","display_name":"IFN-gamma secretion","score":0.7570000290870667},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6420000195503235},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9269999861717224}],"concepts":[{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.7230620384216309},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6961449384689331},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.694137454032898},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5960230827331543},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5350597500801086},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5323837995529175},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5264485478401184},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5206707715988159},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4947335422039032},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.46834108233451843},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.4594515264034271},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4548138380050659},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.4521099627017975},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4323037564754486},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.39180222153663635},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34197190403938293},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2281419038772583},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.11771216988563538},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11604645848274231},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.11425265669822693},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0969424843788147},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.07293099164962769},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4049/jimmunol.196.supp.74.10","doi":"https://doi.org/10.4049/jimmunol.196.supp.74.10","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.196.supp.74.10","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2885771784","https://openalex.org/W2887100062","https://openalex.org/W2138428661","https://openalex.org/W2091517922","https://openalex.org/W2511100615","https://openalex.org/W4388080469","https://openalex.org/W2610257765","https://openalex.org/W2431004354","https://openalex.org/W2321640347","https://openalex.org/W4239468914"],"abstract_inverted_index":{"Abstract":[0],"KRAS":[1],"mutations":[2],"accounts":[3],"for":[4,35,243],"about":[5],"30%":[6],"of":[7,17,21,46,52,60,89,97,112,140,152,166,180,203,216,234,245],"human":[8],"non-small":[9],"cell":[10,160],"lung":[11,22,36,250],"cancer":[12,37],"(NSCLC)":[13],"and":[14,55,212],"represent":[15],"one":[16],"key":[18],"oncogenic":[19],"drivers":[20],"cancer.":[23],"While":[24],"recent":[25],"advances":[26],"in":[27,50,84,122,127,131,157,198,208],"targeted":[28],"therapy":[29,34,183],"have":[30],"shown":[31],"promise,":[32],"effective":[33],"still":[38],"remains":[39],"a":[40,72,220],"challenge.":[41],"Given":[42],"the":[43,56,98,110,132,137,185,201,214,224,231],"demonstrated":[44],"efficacy":[45],"BET":[47,99,236],"bromodomain":[48,100,237],"inhibitors":[49],"treatment":[51,117,146,155,244],"hematologic":[53],"malignancies":[54,247],"emerging":[57],"clinical":[58],"benefit":[59],"immunotherapeutic":[61],"agents":[62,77],"such":[63,248],"as":[64,249],"anti-PD1":[65],"antibody,":[66,105],"we":[67,106],"sought":[68],"to":[69,80,136,149,189,193],"determine":[70],"whether":[71],"combinatorial":[73],"approach":[74],"involving":[75],"these":[76],"could":[78],"synergize":[79],"promote":[81],"anti-tumor":[82],"response":[83],"genetically":[85],"engineered":[86],"mouse":[87],"model":[88],"NSCLC":[90],"harboring":[91],"activating":[92],"kras":[93],"mutation.":[94],"Upon":[95],"administration":[96],"inhibitor":[101],"JQ1,":[102],"and/or":[103],"\u03b1-PD-1":[104],"evaluated":[107],"by":[108,163],"FACS,":[109],"dynamics":[111],"tumor-associated":[113],"immune":[114,240],"cells.":[115,142,171],"Notably,":[116],"with":[118,124,239],"JQ1":[119,145],"alone":[120,147],"or":[121],"combination":[123,202],"\u03b1-PD1":[125,154],"resulted":[126,156],"increased":[128,164],"CD8:Treg":[129],"ratio":[130],"tumors,":[133],"likely":[134],"due":[135],"reduced":[138],"proportions":[139],"Treg":[141],"Interestingly,":[143],"while":[144],"led":[148],"remarkable":[150],"down-regulation":[151],"PD-1,":[153],"augmented":[158],"T":[159,170,175],"activation":[161],"evidenced":[162],"expression":[165],"CD69":[167],"on":[168],"tumor-CD8+":[169],"When":[172],"tested":[173],"ex-vivo,":[174],"cells":[176],"isolated":[177],"from":[178],"tumors":[179],"double":[181],"agent":[182,195],"showed":[184],"most":[186],"enhanced":[187],"ability":[188],"secrete":[190],"IFN-\u03b3":[191],"relative":[192],"either":[194],"alone.":[196],"Lastly,":[197],"survival":[199,215],"studies,":[200],"both":[204],"drugs":[205],"was":[206],"superior":[207],"reducing":[209],"tumor":[210],"burden":[211],"prolonged":[213],"tumor-bearing":[217],"mice":[218],"demonstrating":[219],"synergistic":[221],"effect":[222],"between":[223],"two":[225],"agents.":[226],"Collectively,":[227],"our":[228],"findings":[229],"highlight":[230],"therapeutic":[232],"potential":[233],"combining":[235],"inhibition":[238],"checkpoint":[241],"blockade":[242],"solid":[246],"adenocarcinomas.":[251]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2017-11-17T00:00:00"}